Yang, H.;                     Gan, L.;                     Zhang, H.    
        Design, Synthesis, Anticancer Evaluation and Molecular Docking of Pyrimidine, Pyrido[4,3-d]pyrimidine and 5,6,7,8-Tetrahydropyrido[3,4-d]pyrimidine Derivatives as Novel KRAS-G12D Inhibitors and PROTACs. Pharmaceuticals 2025, 18, 696.
    https://doi.org/10.3390/ph18050696
    AMA Style
    
                                Yang H,                                 Gan L,                                 Zhang H.        
                Design, Synthesis, Anticancer Evaluation and Molecular Docking of Pyrimidine, Pyrido[4,3-d]pyrimidine and 5,6,7,8-Tetrahydropyrido[3,4-d]pyrimidine Derivatives as Novel KRAS-G12D Inhibitors and PROTACs. Pharmaceuticals. 2025; 18(5):696.
        https://doi.org/10.3390/ph18050696
    
    Chicago/Turabian Style
    
                                Yang, Hailong,                                 Lu Gan,                                 and Huabei Zhang.        
                2025. "Design, Synthesis, Anticancer Evaluation and Molecular Docking of Pyrimidine, Pyrido[4,3-d]pyrimidine and 5,6,7,8-Tetrahydropyrido[3,4-d]pyrimidine Derivatives as Novel KRAS-G12D Inhibitors and PROTACs" Pharmaceuticals 18, no. 5: 696.
        https://doi.org/10.3390/ph18050696
    
    APA Style
    
                                Yang, H.,                                 Gan, L.,                                 & Zhang, H.        
        
        (2025). Design, Synthesis, Anticancer Evaluation and Molecular Docking of Pyrimidine, Pyrido[4,3-d]pyrimidine and 5,6,7,8-Tetrahydropyrido[3,4-d]pyrimidine Derivatives as Novel KRAS-G12D Inhibitors and PROTACs. Pharmaceuticals, 18(5), 696.
        https://doi.org/10.3390/ph18050696